BAQSIMI

Swiss trademark · 690370 · Word mark · In force

Register entry

Registration number
690370
Application number
54987/2016
Status
In force
Type
Word mark
Filed
Apr 22, 2016
Registered
Jul 13, 2016
Published
Jul 13, 2016
Protected until
Apr 22, 2036
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von diabetesbezogener Hypoglykämie einschliesslich niedriger Blutzuckerspiegel, diabetesbezogener Insulinschock und Insulinreaktion.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 26, 2026

    Renewed

    Expiry date
    22.04.2026 → 22.04.2036

    Published in Swissreg on 26.03.2026

  2. Jan 12, 2024

    Agent removed

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich (removed)

    Published in Swissreg on 12.01.2024

  3. Jan 12, 2024

    Transferred

    Owner
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA → Amphastar Pharmaceuticals, Inc., 11570 Sixth Street, Rancho Cucamonga, CA 91730, USA
    Representative
    Walder Wyss AG, Seefeldstrasse 123, Postfach, 8034 Zürich

    Published in Swissreg on 12.01.2024

  4. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  5. Jul 13, 2016

    Registered

    Published in Swissreg on 13.07.2016

Parties

Holder

Amphastar Pharmaceuticals, Inc.

11570 Sixth Street, Rancho Cucamonga, CA 91730, US

Agent

Walder Wyss AG

Seefeldstrasse 123 Postfach, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.